Ovarian Cancer Trial, Recruiting NCT06800105 Sponsor: University of Tennessee Graduate School of Medicine Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT06800105
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are women and are over 18 years old
  • People who are currently being evaluated by doctors for a suspected ovarian cancer diagnosis
  • People whose planned treatment involves surgery to remove as much cancer as possible, followed by chemotherapy
  • People who are able to attend all required study visits
  • People who have internet access and can be reliably contacted by phone, email, or text message

Who may not be able to join:

  • People who are currently pregnant
  • People who are not able to give their own free and voluntary consent to participate
  • People who are unable to eat the specific meals or snacks required before and during study visits due to strict dietary restrictions
  • People who use illicit substances such as cocaine, methamphetamines, heroin, or other street drugs (note: use of marijuana, CBD oil, or related supplements will be reviewed individually by the research team)
  • People whose personal circumstances or health condition would make it difficult to follow the study requirements, as assessed by the research team

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 8653059367

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Tennessee Graduate School of Medicine
Registry
ClinicalTrials.gov
Start date
22 March 2023
Est. completion
31 March 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility assessed by attrition; Feasibility and acceptability assessed by protocol adherence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov